Clinical trial
A Prospective, Multi-Center, Observational Biomarker Real-World Evidence Study for In-Depth Profiling of Patients With Chronic Immune-Mediated Inflammatory Skin Diseases in Daily Practice
NCT07021495 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Observational Biomarker Real-World Evidence Study for In-Depth Profiling of Patients With Chronic Immune-Mediated Inflammatory Skin Diseases in Daily Practice
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 29, 2025
- Completion date
- December 31, 2029
- Enrollment
- 840 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis (ad), chronic spontaneous urticaria (csu), ctcl/ mycosis fungoides, hidradenitis suppurativa (hs), psoriasis (pso)